Fig. 2From: Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analysesHazard rates of relapse of breast cancer patients after diagnosis according to the AJCC response criteriaBack to article page